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Volume 49, Number 3 Abstracts 813diabetic patients treated in this series is gratifying. Patients with diabetes and
walking impairment, without evidence of peripheral vascular disease, should
be considered for a diagnosis of CECS. Fasciotomy in well-selected patients
appears to be efficacious.
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Conclusions: In patients with deep venous thrombosis (DVT), local
abnormalities of the inferior vena cava (IVC), malignancy, and lupus anti-
coagulants are associated with increased risk of IVC thrombosis. IVC
thrombosis is associated with high risk of symptomatic pulmonary embolism
(PE) as well.
Summary: IVC thrombosis is relatively rare, and venous thromboem-
bolism risk factors that contribute to the development of IVC thrombosis
are not well characterized. The authors reviewed available cases of IVC
thrombosis registered in the MAISTHRO (Main-IS-ar-THROmbosis) da-
tabase. This registry enrolled 1770 consecutive patients with a documented
history of acute venous thromboembolism treated at university hospitals in
Frankfurt and Wurzburg, Germany. The authors identified 53 patients (35
males, 18 females) with IVC thrombosis between the ages of 12 to 79 yearsand selected as controls 265 patients with lower extremity DVTmatched for
age and gender from the MAISTHRO database. Diagnostic procedures for
PE were performed for clinical indications.
Of the 53 patients with IVC thrombosis, thrombosis developed in 40
(75.5%) before the age of 45. Local problems such as external venous
compression or IVC anomalies were identified in 22.6% as contributing to
the thrombosis. Lupus anticoagulants (10.9% vs 2.3%, P  .013) and
malignancy (17.0% vs 6.4%, P  .023) were more prevalent in the ICV
thrombosis patients vs the matched controls. No differences were found
between the IVC thrombosis patients and thematched controls for inherited
thrombophilias or other known VTE risk factors. Symptomatic PE occurred
in 32.1% of the IVC thrombosis patients and in 15.2% of the controls (P 
.005).
Comment: Although IVC thrombosis is a subset of DVT, it appears to
have slightly different predisposing factors compared with patients with
DVT isolated to the lower extremity. In particular, the study identified local
abnormalities of the vena cava, external compression of the vena cava from
neighboring pathologic processes, malignancy, and the presence of an-
tiphospholipid antibody syndrome as important predisposing factors to IVC
thrombosis. Patients with IVC thrombosis should therefore be investigated
for malignancy and the presence of antiphospholipid antibody syndrome.
The risk of symptomatic PE appears quite high. It may be reasonable to
consider the placement of a prophylactic vena cava filter.
